Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dmitry V Bulavin

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Oncotarget|February 16, 2017
Cancer suppression by systemic inactivation of p38MAPKAnna Brichkina, Dmitry V Bulavin
Clinical Science (London, England : 1979)|May 29, 2026
A cross-talk between p16High senescence and cellular reprogrammingAlexander Emelyanov, Dmitry V Bulavin
Cancer Biology & Therapy|July 16, 2008
PPM1H--new kid on the blockSathyavageeswaran Shreeram, Dmitry V Bulavin
Aging|June 15, 2020
LSEC model of agingLaurent Grosse, Dmitry V Bulavin
Autophagy|August 17, 2012
WIP-ing out atherosclerosis with autophagyAnna Brichkina, Dmitry V Bulavin
Advances in Cancer Research|November 9, 2004
p38 MAP kinase's emerging role as a tumor suppressorDmitry V Bulavin, Albert J Fornace
Progress in Molecular Biology and Translational Science|February 21, 2012
Wip1-dependent signaling pathways in health and diseasesYun-Hua Zhu, Dmitry V Bulavin
Oncotarget|July 30, 2014
Oncogene-mediated regulation of p53 ISGylation and functionsYi-Fu Huang, Dmitry V Bulavin
Trends in Biochemical Sciences|November 3, 2009
WIP1 phosphatase at the crossroads of cancer and agingXavier Le Guezennec, Dmitry V Bulavin
Cell Cycle (Georgetown, Tex.)|September 3, 2005
Inhibition of the ATR/Chk1 pathway induces a p38-dependent S-phase delay in mouse embryonic stem cellsLudmila Jirmanova, Dmitry V Bulavin, Albert J Fornace
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Oncotarget|February 16, 2017
Cancer suppression by systemic inactivation of p38MAPKAnna Brichkina, Dmitry V Bulavin
Clinical Science (London, England : 1979)|May 29, 2026
A cross-talk between p16High senescence and cellular reprogrammingAlexander Emelyanov, Dmitry V Bulavin
Cancer Biology & Therapy|July 16, 2008
PPM1H--new kid on the blockSathyavageeswaran Shreeram, Dmitry V Bulavin
Aging|June 15, 2020
LSEC model of agingLaurent Grosse, Dmitry V Bulavin
Autophagy|August 17, 2012
WIP-ing out atherosclerosis with autophagyAnna Brichkina, Dmitry V Bulavin
Advances in Cancer Research|November 9, 2004
p38 MAP kinase's emerging role as a tumor suppressorDmitry V Bulavin, Albert J Fornace
Progress in Molecular Biology and Translational Science|February 21, 2012
Wip1-dependent signaling pathways in health and diseasesYun-Hua Zhu, Dmitry V Bulavin
Oncotarget|July 30, 2014
Oncogene-mediated regulation of p53 ISGylation and functionsYi-Fu Huang, Dmitry V Bulavin
Trends in Biochemical Sciences|November 3, 2009
WIP1 phosphatase at the crossroads of cancer and agingXavier Le Guezennec, Dmitry V Bulavin
Cell Cycle (Georgetown, Tex.)|September 3, 2005
Inhibition of the ATR/Chk1 pathway induces a p38-dependent S-phase delay in mouse embryonic stem cellsLudmila Jirmanova, Dmitry V Bulavin, Albert J Fornace
Pageof 6